National Academy of Agricultural Sciences (NAAS)
|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Malaria is a significant health problem in the tropics, with increasing morbidity and mortality. Children are the population group with the highest malaria case fatality rate. Severe. This will be the first study to investigate the efficacy of a twice-daily regimen versus the three-times daily quinine regimen in treating severe complicated Plasmodium falciparum malaria in Sudan. This was a prospective, cross-sectional, comparative hospital-based study. It was conducted in Wad Medani Pediatrics' Teaching Hospital in Gezeira state (Sudan).The study sample was divided into two groups: the first group was children who received quinine at a dose of 10 mg/kg three times a day, and the second group was those who received it at 10mg/kg twice a day. The groups were followed during their hospital stay for the differences in temperature drop, hypoglycemia, coma resolution, parasite clearance, recrudescence, and quinine side effects. 200 patients were included in this study. The mean age of presentation was 4.5 years. Fever was the most common presenting symptom in half of the patients (101 patients), 50.5%, but on examination, all the patients in the study group were febrile 100%. Low blood sugar levels were more common among the three times group in comparison with the twice daily group, 20% compared to 15% respectively on D1, 10% compared to only 2% on D2, Quinine side effects (chinqunism) were reported more frequently in quinine three times group than twice group 33% of patients of three times group developed vomiting and abdominal pain after starting of quinine on day 1,22%on D2,56 % develop tinnitus on D1,48 % on D2,38% on D3, Two patients develop transient visual loss for the 1st 2days. 20% develop tinnitus on D1,5% on D2. 19 % of patients of the times quinine group had parasite recrudescence during follow-up (appearance of symptoms of Malaria with positive blood film) two patients on day 14 and the remaining 17 patients on day 28 and the cause of this parasite recrudescence most probably was due to their poor compliance (missing the dose, stopping quinine prematurely when they felt an improvement of their children among those patients), comparing to only4 patients of twice group. Our study found no statistically significant differences between the two quinine regimens in fever remission time, parasite clearance, and coma resolution time. However, the twice-quinine regimen was associated with less chinqunism (quinine side effect) and a lower risk of hypoglycemia.
Achan J, Talisuna A O, Erhart A, Yeka A, Tibenderana J K, Baliraine F N, et al., Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malaria journal. 2011;10(1):144. https://doi.org/10.1186/1475-2875-10-144
Adam I, Ibrahim M, Elbashir M. Low-dose quinine for treatment of chloroquine-resistant falciparum malaria in Sudanese pregnant women. Eastern Mediterranean health journal= La revue de sante de la Mediterraneeorientale= al-Majallah al-sihhiyah li-sharq al-mutawassit. 2004;10(4-5):554-9. https://doi.org/10.26719/2004.10.4-5.554
Akande T, Musa I. Epidemiology of malaria in Africa. African Journal of Clinical and Experimental Microbiology. 2005;6(2):107-11. https://doi.org/10.4314/ajcem.v6i2.7409
Bardají A, Bassat Q, Alonso P L, Menéndez C. Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidence. Expert opinion on pharmacotherapy. 2012;13(12):1719-36. https://doi.org/10.1517/14656566.2012.703651
Bazie. E. A. (2024). Retinopathy in Cerebral Malaria. Journal of Ophthalmic Research and Discoveries. The Geek Chronicles. 1(1): 1-8 https://www.doi.org/jord.2024.tgc.0293
Bisht H S, Goel M, Gupta A K, Tandon A, Srivastava A K, Solanki S. Differential Criteria to Evaluate Parasite (Plasmodium) and Bacteria (Salmonella) for Diagnosis of Malaria and Typhoid Fever. 2015.
Breman J G. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. The American journal of tropical medicine and hygiene. 2001;64(1_suppl):1-11. https://doi.org/10.4269/ajtmh.2001.64.1
Burrows J N and Wells T N. Development of medicines for the control and elimination of malaria. Advances in Malaria Research. 2016:353.
Caraballo H and King K. Emergency department management of mosquitoborne illness: malaria, dengue, and West Nile virus. Emergency medicine practice. 2014;16(5):1-23; quiz -4.
Cowman A F, Healer J, Marapana D, Marsh K. Malaria: biology and disease. Cell. 2016;167(3):610-24. https://doi.org/10.1016/j.cell.2016.07.055
Cui L, Yan G, Sattabongkot J, Cao Y, Chen B, Chen X, et al., Malaria in the Greater Mekong Subregion: heterogeneity and complexity. Actatropica. 2012;121(3):227-39. g 60. https://doi.org/10.1016/j.actatropica.2011.02.016
Elased K, Playfair J. Hypoglycemia and hyperinsulinemia in rodent models of severe malaria infection. Infection and immunity. 1994;62(11):5157-60. https://doi.org/10.1128/iai.62.11.5157-5160.1994
Elkhalifa, A. M. E., Abdul-Ghani, R., Tamomh, A. G. et al., Hematological indices and abnormalities among patients with uncomplicated falciparum malaria in Kosti city of the White Nile state, Sudan: a comparative study. BMC Infect Dis 21, 507 (2021). https://doi.org/10.1186/s12879-021-06228-y
Elmardi K A, Malik E M, Abdelgadir T, Ali S H, Elsyed A H, Mudather M A, et al., Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan's conditions using artemisinin-based combination therapy and rapid diagnostic test. Malaria journal. 2009;8(1):39. https://doi.org/10.1186/1475-2875-8-39
Elsharif Ahmed Bazie, Abazar Mahmoud Ismail, Bashir Abdullah Salad, Masharig Tarig Mohamed, Nosyba Mustafa, Muram Elabid Elkhadir, Elgot Khalid Khalifa. 2016. Effect of malaria on: Serum K, Serum Na and Blood urea- Sudan. European Academic Research - Vol. IV, Issue 7.
Frédérich M, Dogné J-M, Angenot L, Mol P. New trends in anti-malarial agents. Current medicinal chemistry. 2002;9(15):1435-56. https://doi.org/10.2174/0929867023369691
Freedman D O. Malaria prevention in short-term travelers. New England Journal of Medicine. 2008;359(6):603-12. https://doi.org/10.1056/NEJMcp0803572
Gething P W, Smith D L, Patil A P, Tatem A J, Snow R W, Hay S I. Climate change and the global malaria recession. Nature. 2010;465(7296):342. https://doi.org/10.1038/nature09098
Guinovart C, Navia M, Tanner M, Alonso P. Malaria: burden of disease. Current molecular medicine. 2006;6(2):137-40. https://doi.org/10.2174/156652406776055131
Harper K, Armelagos G. The changing disease-scape in the third epidemiological transition. International Journal of Environmental Research and Public Health. 2010;7(2):675-97. https://doi.org/10.3390/ijerph7020675
Ibrahim M, Elbashir M, Naser A, Aelbasit I, Kheir M, Adam I. Low-dose quinine is effective in the treatment of chloroquine-resistant Plasmodium falciparum malaria in eastern Sudan. Annals of Tropical Medicine & Parasitology. 2004;98(5):441-5 https://doi.org/10.1179/000349804225003488
Kofoed P-E, Lopes F, Johansson P, Dias F, Sandström A, Aaby P, et al., Lowdose quinine for treatment of Plasmodium falciparum malaria in Guinea-Bissau. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1999;93(5):547-9. https://doi.org/10.1016/s0035-9203(99)90377-2
Ligon B L, (2006). Infectious diseases that pose specific challenges after natural disasters: a review. Jan;17(1):36-45. https://doi.org/10.1053/j.spid.2006.01.002
Malaria W E Co, Organization WH. WHO expert committee on malaria: twentieth report: World Health Organization; 2000.
Murphy S C and Breman J G. Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. The American journal of tropical medicine and hygiene. 2001;64(1_suppl):57-67. https://doi.org/10.4269/ajtmh.2001.64.57
Network T M G E. A global network for investigating the genomic epidemiology of malaria. Nature. 2008;456(7223):732 -7. https://doi.org/10.1038/nature07632
Organization WH. Guidelines for the treatment of malaria: World Health Organization; 2015.
Organization WH. WHO malaria terminology. 2016.
Reyburn H. New WHO guidelines for the treatment of malaria. BMJ (Clinical research ed). 2010;340:c2637. g 59 https://doi.org/10.1136/bmj.c2637
Winstanley P, Ward S, Snow R, Breckenridge A. Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy. Clinical microbiology reviews. 2004;17(3):612-37. https://doi.org/10.1128/CMR.17.3.612-637.2004
Yeka A. Management of un-complicated falicaparum malaria in Uganda: Appropriate treatment options for the primary and recurrent malaria infections in children: UniversiteitAntwerpen (Belgium); 2013.
Citations |
 |
 |
 |
 |
